PTHS icon

Pelthos Therapeutics (PTHS)

AMEX

$27.10

$0.100 (

+0.37%

)

1D
5D
1M
6M
1Y
5Y
Market closed

PTHS: $27.10 / ₿ 0.0003 BTC / 34937 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$27.00
$9.00 - $54.29
$94.19M
10.1
3.48M
$26.47 - $30.00
Yes

What is Pelthos Therapeutics (PTHS)?

Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMITM, XEPI, and XEGLYZE. The company operates in two reporting segments: the sale, promotion, and commercialization of approved commercial products, the Commercial Operations segment, and research and development activities related to developing a novel and proprietary class of NaV blockers that target the body's peripheral nervous system; and supportive activities to expand the NITRICIL nitric oxide-based technology.

The Pelthos Therapeutics (PTHS) stock price has been rising

The Pelthos Therapeutics Inc. (PTHS) stock price today is $27.10, reflecting a +0.37% move since the market opened. The company’s market capitalization stands at $94.19M, with a daily trading volume of shares. The previous closing price was $27.00.

Get started with Pelthos Therapeutics (PTHS)

Ready to get started? Follow the steps below, or read our guide on how to buy Pelthos Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy PTHS

Search for PTHS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy PTHS.

PTHS FAQs

PTHS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

PTHS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Pelthos Therapeutics Inc. (PTHS) has traded between a low of $9.00 and a high of $54.29.

PTHS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Pelthos Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
PTHS icon
PTHS

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

TSEOF icon

TSEOF

EPWKF icon
YHNAR icon

YHNAR

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

TTOO icon
SMFL icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.